Portal de Periódicos da CAPES

Alcohol, Hepatotropic Viruses, and Hepatocellular Carcinoma

1995; Wiley; Volume: 19; Issue: 5 Linguagem: Catalão

10.1111/j.1530-0277.1995.tb01585.x

1530-0277

Bertrand Nalpas, Mark A. Feitelson, Christian Bréchot, Emanuel Rubin,

Hepatitis B Virus Studies

Alcoholism: Clinical and Experimental ResearchVolume 19, Issue 5 p. 1089-1095 Alcohol, Hepatotropic Viruses, and Hepatocellular Carcinoma Bertrand Nalpas, Corresponding Author Bertrand Nalpas Service ďHépatologie, Hôpital Necker INSERM U-99, Paris, FranceReprints requests: Bertrand Nalpas, M.D., Ph.D., Service ďHépatologie, Hôpital Necker, 149 rue de Sèvres, 75347 Paris, Cedex 15, FranceSearch for more papers by this authorMark Feitelson, Mark Feitelson Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.Search for more papers by this authorChristian Bréchot, Christian Bréchot Service ďHépatologie, Hôpital Necker INSERM U-370, Paris, FranceSearch for more papers by this authorEmanuel Rubin, Emanuel Rubin Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.Search for more papers by this author Bertrand Nalpas, Corresponding Author Bertrand Nalpas Service ďHépatologie, Hôpital Necker INSERM U-99, Paris, FranceReprints requests: Bertrand Nalpas, M.D., Ph.D., Service ďHépatologie, Hôpital Necker, 149 rue de Sèvres, 75347 Paris, Cedex 15, FranceSearch for more papers by this authorMark Feitelson, Mark Feitelson Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.Search for more papers by this authorChristian Bréchot, Christian Bréchot Service ďHépatologie, Hôpital Necker INSERM U-370, Paris, FranceSearch for more papers by this authorEmanuel Rubin, Emanuel Rubin Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.Search for more papers by this author First published: October 1995 https://doi.org/10.1111/j.1530-0277.1995.tb01585.xCitations: 16AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Sorensen TIA, Orholm M, Bentsen KD, Hoybye G, Eghoje K, Christoffersen P: Prospective evaluation of alcohol abuse and alcoholic injury in men as predictors or development of cirrhosis. Lancet 2: 241–244, 1984. 2 Grant BF, DeBakey S, Zobeck TS: Liver cirrhosis mortality in the United States, 1973-1988. NIAAA Surveillance Report No. 18. DHHS Publ. No. (ADM) 281-89-0001. Washington , D.C. , Superintendent of Documents, U.S. Government Printing Office, 1991. 3 Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, Cristianini G: Prevalence of chronic liver disease in the general population of northern Italy: The Dionysos Study. Hepatology 20: 1442–1449, 1994. 4 Pettigrew NM, Goudie RB, Russell RI, Chaudhuri AKR: Evidence for a role of hepatitis B virus in chronic alcoholic liver disease. Lancet 2: 724–725, 1972. 5 Mills PR, Pennington TH, Kay P, Macsween RNM, Watkinson G: Hepatitis Bs antibody in alcoholic cirrhosis. J Clin Pathol 32: 778–782, 1979. 6 Hislop WS, Follett EAC, Bouchier IAD, Macsween RNM: Serological markers of hepatitis B in patients with alcoholic liver disease: A multi-centre survey. J Clin Pathol 34: 1017–1019, 1981. 7 Goudeau A, Maupas P, Dubois F, Coursaget P, Bougnoux P: Hepatitis B infection in alcoholic liver disease and primary hepatocellular carcinoma in France. Prog Med Virol 27: 26–34, 1981. 8 Orholm M, Aldershvile J, Tage-Jensen U: Prevalence of hepatitis B infection among alcoholic patients with liver disease. J Clin Pathol 34: 1378–1380, 1981. 9 Saunders JB, Wodak AD, Morgan-Capner P, White YS, Portmann B, Davis M, Williams R: Importance of markers of hepatitis B virus in alcoholic liver disease. Br Med J Clin Res Educ 286: 11851–1854, 1983. 10 Attali P, Thibault N, Buffet C, Briantais MJ, Papoz L, Chaput JC, Etienne JP: Les marqueurs du virus B chez les alcooliques chroniques. Gastroenterol Clin Biol 5: 1095–1102, 1981. 11 Nalpas B, Berthelot P, Thiers V, Duhamel G, Courouce AM, Tiollais P, Brechot C: Hepatitis B virus multiplication in the absence of usual serological markers. A study of 146 alcoholics. J Hepatol 1: 89–97, 1985. 12 Laskus T, Slusarczyk J, Lupa E, Cianciara J: Liver disease among Polish alcoholics. Contribution of chronic active hepatitis to liver pathology. Liver 10: 221–228, 1990. 13 Vetter D, Doffoel M, Gut JP, Doffoel S, North ML, Charrault A, Ventre G, Mayer S, Bockel R: Virus de ľhépatite B, marqueurs sérologiques ďinfections virales et immunityé humorale au cours de la cirrhose alcoolique. Gastroenterol Clin Biol 9: 389–395, 1985. 14 Coste T, Gie A, Fischer D, Karsenti P, Paraf A: Fréquence des marqueurs du virus B chez les alcooliques chroniques avec ou sans cirrhose. Gastroenterol Clin Biol 6: 515–516, 1982 (letter to the editor). 15 Attali P, Proďhomme S, Pelletier G, Papoz L, Buffet C, Etienne JP: Carcinome hépato-cellulaires en France. Aspects cliniques, biologiques et virologiques chez 197 malades. Gastroenterol Clin Biol 9: 396–402, 1985. 16 Brechot C, Nalpas B, Courouce AM, Duhamel G, Callard P, Carnot F, Tiollais P, Berthelot P: Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. N Engl J Med 306: 1384–1387, 1982. 17 Renard P, Hillon P, Bedenne L, Fourot M, Milan C, Faivre J, Klepping C: Marqueurs du virus B et alcoolisme chronique. Prévalence et facteurs favorisants. Ann Gastroenterol Hepatol 27: 7–12, 1991. 18 Leandro G, Colloredo G, Cozzolongo R, Elba S: Hepatocellular carcinoma in cirrhotic patients: Role of hepatitis B virus. Ital J Gastroenterol 22: 66–69, 1990. 19 Nakanuma Y, Ohta G: Morphology of cirrhosis and occurrence of hepatocellular carcinoma in alcoholics with and without HBsAg and in non-alcoholic HBsAg-positive patients. A comparative autopsy study. Liver 3: 231–237, 1983. 20 Lehmann FG, Martini GA: Incidence of primary liver cell carcinoma in liver cirrhosis: 5 year prospective study. Digestion 14: 530–531, 1976. 21 Mendenhall CL, Seeff L, Diehl AM, Ghosn SJ, French SW, Gartside PS, Rouster SD, Buskell-Bales Z, Grossman CJ, Rosselle GA, et al: Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119). Hepatology 14: 581–589, 1991. 22 Nalpas B, Driss F, Pol S, Hamelin B, Housset C, Brechot C, Berthelot P: Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol 12: 70–74, 1991. 23 Laurent-Puig P, Dussaix E, Lecoz Y, Martes P, Buffet C: Prevalence of anti-hepatitis C virus antibodies among patients with alcoholic liver disease, supplemented by 4-RIBA. Dig Dis Sci 37: 156–157, 1992 (letter to the editor). 24 Zarski JP, Thelu MA, Moulin C, Rachail M, Seigneurin JM: Interest of the detection of hepatitis C virus RNA in patients with alcoholic liver disease. Comparison with the HBV status. J Hepatol 17: 10–14, 1993. 25 Bode JC, Biermann J, Kohse KP, Walker S, Bode C: High incidence of antibodies to hepatitis C virus in alcoholic cirrhosis: Fact or fiction Alcohol Alcohol 26: 111–114, 1991. 26 Pares A, Barrera JM, Caballeria J, et al: Hepatitis C virus antibodies in chronic alcoholic patients: Association with severity of liver injury. Hepatology 12: 1295–1299, 1990. 27 Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, Vail M, Bruguera M, Bru C, et al: Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 2: 1004–1006, 1989. 28 Brillanti S, Masci C, Siringo S, Di Febo G, Miglioli M, Barbara L: Serological and histological aspects of hepatitis C virus infection in alcoholic patients. J Hepatol 13: 347–350, 1991. 29 Goeser T, Muller H, Solbach C, Toex U, Kommerell B, Theilmann L: Patients with alcoholic liver cirrhosis and concomitant hepatitis C viraemia are of increased risk to develop hepatocellular carcinoma. Gastroenterology 104: A707, 1993 (abstr). 30 Nishiguchi S, Kuroki T, Yabusako T, Seki S, Kobayashi K, Monna T, Otani S, Sakurai M, Shikata T, Yamamoto S: Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology 14: 985–989, 1991. 31 Shimizu S, Kiyosawa K, Sodeyama T, Tanaka E, Nakano M: High prevalence of antibody to hepatitis C virus in heavy drinkers with chronic liver disease in Japan. J Gastroenterol Hepatol 7: 30–35, 1992. 32 Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N, Houghton M: Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 2: 1006–1008, 1989. 33 Hasan F, Jeffers U, De Medina M, Reddy KR, Parker T, Schiff ER, Houghton M, Choo QL, Kuo G: Hepatitis C-associated hepatocellular carcinoma. Hepatology 12: 589–591, 1990. 34 Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, et al: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12: 671–675, 1990. 35 Rubin E: The chemical pathogenesis of alcohol-induced tissue injury. Alcohol Health Res World 17: 272–278, 1993. 36 Paronetto F: Immunologic reactions in alcoholic liver disease. Se-min Liver Dis 13: 183–195, 1993. 37 Laskus T, Radkowski M, Lupa E, Horban A, Cianciara J, Slusarczyk J: Prevalence of markers of hepatitis viruses in out-patient alcoholics. J Hepatol 15: 174–178, 1992. 38 Joller-Jemelka HI, Wicki AN, Grob PJ: Detection of HBs antigen in “anti-HBc alone” positive sera. J Hepatol 21: 269–272, 1994. 39 Pol S, Thiers V, Nalpas B, Degos F, Gazengel C, Carnot F, Tiollais P, Wands JR, Berthelot P, Brechot C: Monoclonal anti-HBs antibodies radioimmunoassay and serum HBV-DNA hybridization as diagnostic tools of HBV infection: Relative prevalence among HBsAg-negative alcoholics, patients with chronic hepatitis or hepatocellular carcinomas and blood donors. Eur J Clin Invest 17: 515–521, 1987. 40 Jiang JJ, Dubois F, Driss F, et al: Clinical impact of drug addiction in alcoholics. Alcohol Alcohol 30: 55–60, 1995. 41 Zignego AL, Foschi M, Laffi G, Monti M, Careccia G, Romanelli RG, De Majo E, Mazzanti R, Buzzelli G, La Villa G, et al: “Inapparent” hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. Hepatology 19: 577–582, 1994. 42 Lai ME, Farci P, Figus A, Balastrieri, Arnone M, Vyas GN: Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen. Blood 73: 17–19, 1989. 43 Wang JT, Wang TH, Sheu JC, Shih LN, Lin JT, Chen DS: Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of blood donors negative for hepatitis B surface antigen. J Infect Dis 163: 397–399, 1991. 44 Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, Goudeau A, Wands J, Sninsky J, Tiollais P, et al: Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 2: 1273–1276, 1988. 45 Wands JR, Fujita YK, Isselbacher KJ, Degott C, Schellekens H, Dazza MC, Theirs V, Tiollais P, Brechot C: Identification and transmission of hepatitis B virus-related variants. Proc Natl Acad Sci USA 83: 6608–6612, 1986. 46 Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC: Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 2: 588–591, 1989. 47 Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC: Vaccine-induced escape mutant of hepatitis B virus. Lancet 336: 325–329, 1990. 48 Gerken G, Kremsdorf D, Capel F, Petit MA, Dauguet C, Manns, MP, Meyer, Zum Buschenfelde, KH, Brechot C: Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection. Virology 183: 555–565, 1991. 49 Feitelson M, Lega L, Guo J, Resti M, Rossi ME, Azzari C, Blumberg BS, Vierucci A: Pathogenesis of posttransfusion viral hepatitis in children with beta-thalassemia. Hepatology 19: 558–568, 1994. 50 Nakatake H, Chisaka O, Yamamoto S, Matsubara K, Koshy R: Effect of X protein of transactivation of hepatitis B virus promoters and on viral replication. Virology 195: 305–314, 1993. 51 Chen H-S, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH: The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 67: 1218–1226, 1993. 52 Feitelson MA, Duan L-X, Guo J, et al: Precore and region mutants in hepatitis B virus infections among renal dialysis patients. J Viral Hepatitis (in press). 53 Novick DM, Jenkins WJ, Karayiannis P, Thomas HC: A preliminary study of hepatitis B virus replication during short-term (7-day) social drinking. Alcohol Clin Exp Res 11: 556–558, 1987. 54 Ohta Y, Horiike N, Michitaka K, Onji M: Effect of alcohol on the replication of HBV and the integration of HBV DNA into the liver cell of nuclei of patients with chronic hepatitis and hepatocarcinoma, in K Kuriyama, A Takada, H Ishii (eds): Biomedical and Social Aspects of Alcohol and Alcoholism. Amsterdam , Elsevier, 1988, pp 827–830. 55 Babinet C, Farza H, Morello D, Hadchouel M, Pourcel C: Specific expression of hepatitis B surface antigen in transgenic mice. Science 230: 1160–1163, 1985. 56 Nalpas B, Pourcel C, Feldmann G, Housset C, Tiollais P, Brechot C, Berthelot P, Farza H: Chronic alcohol intoxication decreases the serum level of hepatitis B surface antigen in transgenic mice. J Hepatol 15: 118–124, 1992. 57 Nalpas B, Thiers V, Pol S, Driss F, Thepot V, Berthelot P, Brechot C: Hepatitis C viremia and anti-HCV antibodies in alcoholics. J Hepatol 14: 381–384, 1992. 58 Finkelstein SD, Coehlo-Little E, Jeffers LJ, et al: HCV exhibits a higher degree of mutability in patients with a background of alcohol abuse. Gastroenterology 104: A901, 1993 (abstr). 59 Matsuda Y, Takase S, Sawada M, Sato I, Takada A: Effect of alcohol abuse on HCV replication, in the 8th Triennal Congress of the International Symposium on Viral Hepatitis and Liver Disease, Tokyo , Japan , 1993, p 91. 60 Oshita M, Hayashi N, Kashara A, Hagiwara H, Mita E, Naito M, Katayama K, Fusamoto H, Kamada T: Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology 20: 1115–1120, 1994. 61 Brechot C: Hepatitis B virus (HBV) and hepatocellular carcinoma. HBV status and its implication. J Hepatol 4: 269–279, 1987. 62 Brechot C, Hadchouel M, Scotto J, Fonck M, Potet F, Vyas GN: State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci USA 78: 3906–3910, 1981. 63 Chen DS, Hoyer BH, Nelson J, Purcell RH, Gerin JL: Detection and properties of hepatitis B virus DNA in liver tissues from patients with hepatocellular carcinoma. Hepatology 2: 42S–46S, 1982. 64 Korba BE, Wells FV, Baldwin B, Cote PJ, Tennant BC, Popper H, Gerin JL: Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: Presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections. Hepatology 9: 461–470, 1989. 65 Marion PL, van Davelaar MJ, Knight SS, Salazar FH, Garcia G, Popper H, Robinson WS: Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus. Proc Natl Acad Sci USA 83: 4543–4546, 1986. 66 Brechot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, Bismuth H, Trepo C, Benhamou JP, Wands J, et al: Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 312: 270–276, 1985. 67 Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH: Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 18: 1313–1318, 1993. 69 Tokino T, Fukushige S, Nakamura T, Nagaya T, Murotsu T, Shiga K, Aoki N, Matsubara K: Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas. J Virol 61: 3848–3854, 1987. 69 Nagaya T, Nakamura T, Tokino T, Tsurimoto T, Imai M, Mayumi T, Kamino K, Yamamura K, Matsubara K: The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes Dev 1: 773–782, 1987. 70 Hatada I, Tokino T, Ochiya T, Matsubara K: Co-amplification of integrated hepatitis B virus DNA and transforming gene hst-1 in a hepatocellular carcinoma. Oncogene 3: 537–540, 1988. 71 Slagle BL, Zhou ZY, Butel JS: Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome. Cancer Res 51: 49–54, 1991. 72 Takada S, Gotoh Y, Hayashi S, Yoshida M, Koike K: Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues. J Virol 64: 822–828, 1990. 73 Hsu TY, Moroy T, Etiemble J, Louise A, Trepo C, Tiollais P, Buendia MA: Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell 55: 627–635, 1988. 74 De The H, Marchio A, Tiollais P, Dejean A: A novel steroid/ thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma. Nature 330: 667–670, 1987. 75 Wang J, Chenivesse X, Henglein B, Brechot C: Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343: 555–557, 1990. 76 Wu JY, Zhou ZY, Judd A, Cartwright CA, Robinson WS: The hepatitis B virus encoded transcriptional transactivator hbx appears to be a novel protein serine/threonine kinase. Cell 63: 687–695, 1990. 77 Caselmann WH, Meyer M, Kerule AS, Lauer U, Hofschneider PH, Koshy R: A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci USA 87: 2970–2974, 1990. 78 Balsano C, Billet O, Bennoun M, Cavard C, Zider A, Grimber G, Natoli G, Briand P, Levrero M: Hepatitis B virus X gene produce acts as a transactivator in vivo. J Hepatol 21: 103–109, 1994. 79 Wang W, London WT, Feitelson MA: Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res 51: 4971–4977, 1991. 80 Kim C-M, Koike K, Saito I, Miyamura T, Jay G: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317–320, 1991. 81 Zhu M, London WT, Duan L-X, Feitelson MA: The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinoma. Int J Cancer 55: 571–576, 1993. 82 Wollersheim M, Debelka U, Hofschneider PH: A trans-activating function encoded in the hepatitis B virus x gene is conserved in the integrated state. Oncogene 3: 545–552, 1993. 83 Diamantis ID, McGandy CE, Chen T-J, Liaw Y-F, Gudat F, Bianchi L: Hepatitis B X-gene expression in hepatocellular carcinoma. J Hepatol 15: 400–403, 1992. 84 Wang W, London WT, Lega L, Feitelson MA: HBx Ag in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 14: 29–37, 1991. 85 Paterlini P, Poussin K, Kew M, Franco D, Bréchot C: Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21: 313–321, 1995. 86 Hohne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerlich WH: Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J 9: 1137–1145, 1990. 87 Feitelson MA, Zhu M, Duan L-X, London WT: Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8: 1109–1117, 1993. 88 Von Weizsacker F, Blum HE, Wands JR: Polymerase chain reaction analysis of hepatitis B virus DNA in formalin-fixed, paraffin-embedded liver biopsies from alcoholics using simplified and standardized amplification protocol. J Hepatol 20: 646–649, 1994. 89 Walter E, Blum HE, Meier P, Hoenker M, Schmid M, Maier KP, Offensperger WB, Offensperger S, Gerok W: Hepatocellular carcinoma in alcoholic liver disease: No evidence for a pathogenetic role of hepatitis B virus infection. Hepatology 8: 745–748, 1988. 90 Horike N, Michika K, Onji M, Murota T, Ohta Y: HBV DNA hybridization in hepatocellular carcinoma associated with alcohol in Japan. J Med Virol 28: 189–192, 1989. 91 Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P, Brechot C: Persistence of hepatitis B and C viral genomes in primary liver cancers from HBsAg-negative patients: A study of a low-edemic area. Hepatology 17: 20–29, 1993. 92 Liang TJ, Jeffers U, Reddy KR, De Medina M, Parker IT, Cheinquer H, Idroro V, Rabassa A, Schiff ER: Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 18: 1326–1333, 1993. 93 Caporaso N, Romano M, Marmo R, de Sio I, Morisco F, Minerva A, Coltorti M: Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 12: 367–371, 1991. 94 Poynard T, Aubert A, Lazizi Y, Bedossa P, Hamelin B, Terris B, Naveau S, Dubreuil P, Pillot J, Chaput JC: Independent risk factors for hepatocellular carcinoma in French drinkers. Hepatology 13: 896–901, 1991. 95 Miyakawa H, Sato C, Izumi N, Tazawa J, Ebata A, Hattori K, Sakai H, Ikeda T, Hirata R, Sakai Y, et al: Hepatitis C virus infection in alcoholic liver cirrhosis in Japan: Its contribution to the development of hepatocellular carcinoma. Alcohol Alcohol 28S: 85–90, 1993. 96 Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, Kawanishi M: A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18: 47–53, 1993. Citing Literature Volume19, Issue5October 1995Pages 1089-1095 ReferencesRelatedInformation